This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Sanofi. Active years: 2013-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Paris, FR (2013)
- Gilf sur Yvette, FR (2015)
Company Filing History:
2 out of 5,383 
1 out of 1,544 
Years Active: 2013-2015
Title: Angela Marinetti: Innovator in Platinum-N-Heterocyclic Carbene Derivatives
Introduction
Angela Marinetti is a distinguished inventor based in Gilf sur Yvette, France. She has made significant contributions to the field of chemistry, particularly in the development of platinum N-heterocyclic carbene derivatives. With a total of 2 patents to her name, her work has implications for therapeutic applications.
Latest Patents
Angela's latest patents focus on the preparation and therapeutic use of platinum N-heterocyclic carbene derivatives. These derivatives are characterized by a general formula that includes various aryl or alkyl groups, cycloalkyl groups, and nitrogenous heteroatoms. The innovative aspects of her patents lie in the unique combinations of these elements, which can lead to new therapeutic possibilities.
Career Highlights
Throughout her career, Angela has worked with prominent organizations such as the Centre National De La Recherche Scientifique and Sanofi. Her experience in these institutions has allowed her to advance her research and contribute to significant scientific advancements.
Collaborations
Angela has collaborated with notable colleagues, including Patrick Mailliet and Myriem Skander. These partnerships have enriched her research and expanded the impact of her inventions.
Conclusion
Angela Marinetti's work in the field of platinum N-heterocyclic carbene derivatives showcases her innovative spirit and dedication to advancing therapeutic applications. Her contributions continue to influence the scientific community and pave the way for future discoveries.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile